在2型骨头骨骨缩症中的SMCHD1遗传变异以及预测病原性和疾病透性的挑战
Laurène Gérard1, Mégane Delourme2, Charlotte Tardy1,2
1Service de Génétique Médicale, Biogénopôle, Hôpitaux Universitaires de Marseille, Marseille, France.
European journal of human genetics : EJHG
|December 26, 2024
概括
面肌缩症2型 (FSHD2) 诊断是通过识别SMCHD1基因变异或半双相性来改进的. 40%的D4Z4甲基化值有助于诊断FSHD2,而不是FSHD1.1.
科学领域:
- 遗传学 是一个遗传学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 1型 (FSHD1) 肌肉衰竭的诊断包括一个缩短的D4Z4阵列.
- 面骨肌缩症2型 (FSHD2) 以前是由于缺少缩短的D4Z4等位基因而被诊断出来的,但现在大多数病例都与SMCHD1基因变异有关.
- 无论是FSHD1还是FSHD2,都表现出减少的D4Z4DNA甲基化.
研究的目的:
- 通过在临床诊断的FSHD患者中调查SMCHD1变异来完善FSHD2的分子诊断.
- 根据SMCHD1状态和D4Z4甲基化水平,建立FSHD2的诊断标准.
- 评估新型和以前分类的SMCHD1变种的致病性.
主要方法:
- 在54名临床FSHD患者中对SMCHD1的分子诊断.
- 对D4Z4阵列长度和cis重复的分析.
- 基因和表观遗传学分析,包括在DR1部位的D4Z4甲基化量化.
- 使用解释和蛋白质结构预测工具进行变异性致病性评估.
主要成果:
- 在54名患者中,有48名患者携带SMCHD1变体,其中6名患者为含SMCHD1.1的18p32位元半.
- 在DR1部位的D4Z4甲基化值为40%,与SMCHD1变体或半性有关.
- 这些患者中最短的4q等位基因在11到35个D4Z4单位之间.
- 突出了解释特定SMCHD1变异的功能影响的挑战.
结论:
- SMCHD1变体或半双相性,以及D4Z4甲基化水平低于40%,是FSHD2诊断的关键分子标记.
- 这项研究澄清了FSHD2的遗传和表观遗传特征,使其与FSHD1.1区分开来.
- 需要进一步的研究,才能充分理解SMCHD1在FSHD病变发生中的结构功能关系.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.4K
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
9.6K
相关概念视频
Sex-linked Disorders
97.8K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
97.8K
Incomplete Dominance
20.2K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
20.2K
Pleiotropy
37.6K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
37.6K
Genome-wide Association Studies-GWAS
12.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.0K
Single Nucleotide Polymorphisms-SNPs
13.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.5K
Genetic Lingo
98.3K
Overview
98.3K
